Gene · 2798
Papers2,995
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,995
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The therapeutic potential of targeting cardiac RGS4. | Ther Adv Cardiovasc Dis | 2023 | 37724539 | PubTator, text mining | PubMed |
| Key features of puberty onset and progression can help distinguish self-limited delayed puberty from congenital hypogonadotrophic hypogonadism. | Front Endocrinol (Lausanne) | 2023 | 37701896 | PubTator, text mining | PubMed |
| Novel Correlation between TGF-β1/-β3 and Hormone Receptors in the Human Corneal Stroma. | Int J Mol Sci | 2023 | 37686439 | PubTator, text mining | PubMed |
| JNK Cascade-Induced Apoptosis-A Unique Role in GqPCR Signaling. | Int J Mol Sci | 2023 | 37686335 | PubTator, text mining | PubMed |
| Recovery and Characterization of Spermatozoa in a Neotropical, Terrestrial, Direct-Developing Riparian Frog (Craugastor evanesco) through Hormonal Stimulation. | Animals (Basel) | 2023 | 37684953 | PubTator, text mining | PubMed |
| Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis. | CNS Drugs | 2023 | 37679579 | PubTator, text mining | PubMed |
Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High-Grade Gliomas. | J Proteome Res | 2023 | 37651309 | PubTator, text mining | PubMed |
| GNRH2 Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy. | Anticancer Res | 2023 | 37648321 | PubTator, text mining | PubMed |
| Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016-2022). | Pharmaceuticals (Basel) | 2023 | 37631077 | PubTator, text mining | PubMed |
| Obesity Contributes to Transformation of Myometrial Stem-Cell Niche to Leiomyoma via Inducing Oxidative Stress, DNA Damage, Proliferation, and Extracellular Matrix Deposition. | Genes (Basel) | 2023 | 37628676 | PubTator, text mining | PubMed |
| Glucocorticoids and Their Receptor Isoforms: Roles in Female Reproduction, Pregnancy, and Foetal Development. | Biology (Basel) | 2023 | 37626990 | PubTator, text mining | PubMed |
| The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma. | Open Life Sci | 2023 | 37588995 | PubTator, text mining | PubMed |
| Identification of adipose tissue transcriptomic memory of anorexia nervosa. | Mol Med | 2023 | 37582711 | PubTator, text mining | PubMed |
| Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy). | Adv Ther | 2023 | 37568061 | PubTator, text mining | PubMed |
| The influence of adalimumab treatment on the systemic gene expression in patients with psoriatic arthritis - preliminary report. | Arch Med Sci | 2023 | 37560743 | PubTator, text mining | PubMed |
| Profile of Relugolix in the Management of Advanced Hormone-Sensitive Prostate Cancer: Design, Development, and Place in Therapy. | Drug Des Devel Ther | 2023 | 37559910 | PubTator, text mining | PubMed |
| Exome sequencing to explore the possibility of predicting genetic susceptibility to the joint occurrence of polycystic ovary syndrome and Hashimoto's thyroiditis. | Front Immunol | 2023 | 37545519 | PubTator, text mining | PubMed |
| Olfactory modulation of stress-response neural circuits. | Exp Mol Med | 2023 | 37524867 | PubTator, text mining | PubMed |
| Investigation of the Effects of Metallic Nanoparticles on Fertility Outcomes and Endocrine Modification of the Hypothalamic-Pituitary-Gonadal Axis. | Int J Mol Sci | 2023 | 37511445 | PubTator, text mining | PubMed |
| Locked Out: Phoenixin-14 Does Not Cross a Stem-Cell-Derived Blood-Brain Barrier Model. | Brain Sci | 2023 | 37508911 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2798/papers?page=10